Can pharmacological receptor tyrosine kinase inhibitors sensitize poor outcome breast tumors to immune-based therapies?
about
Can pharmacological receptor tyrosine kinase inhibitors sensitize poor outcome breast tumors to immune-based therapies?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Can pharmacological receptor t ...... ors to immune-based therapies?
@ast
Can pharmacological receptor t ...... ors to immune-based therapies?
@en
type
label
Can pharmacological receptor t ...... ors to immune-based therapies?
@ast
Can pharmacological receptor t ...... ors to immune-based therapies?
@en
prefLabel
Can pharmacological receptor t ...... ors to immune-based therapies?
@ast
Can pharmacological receptor t ...... ors to immune-based therapies?
@en
P2860
P356
P1476
Can pharmacological receptor t ...... ors to immune-based therapies?
@en
P2093
Josie Ursini-Siegel
P2860
P356
10.3389/FONC.2013.00023
P577
2013-02-13T00:00:00Z